- RUBY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Rubius Therapeutics (RUBY) 10-K/A2018 FY Annual report (amended)
Filed: 15 May 19, 7:45am
Exhibit 31.4
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATIONS
I, Andrew M. Oh, certify that:
1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Rubius Therapeutics, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: May 15, 2019 |
| By: | /s/ Andrew M. Oh |
|
|
| Andrew M. Oh |
|
|
| Chief Financial Officer |
|
|
| (Principal Financial Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.